Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 74
Selected: 0
NCT IDTitle
NCT02595073Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis
NCT04134273Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
NCT00291057Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
NCT03880357To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
NCT00244439Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
NCT00828568Bioequivalence Study of Two Imiquimod Cream 5%
NCT01769664A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris
NCT00927472Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT00833079Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
NCT02933502Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
NCT02709902Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris
NCT06733402A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris
NCT03257943A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%
NCT02578043A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris
NCT03094403To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel
NCT02933879Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
NCT02595008Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis
NCT02983981Topical Psoriasis Study for Patients Receiving Biologic Therapy
NCT01876550A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.
NCT02411955A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT00506012Pilot Efficacy Study of T2000 in Myoclonus Dystonia
NCT00835510Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis
NCT03689010To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea
NCT02601469Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
NCT00963508Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT02413229A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study
NCT01206660Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis
NCT02933866Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
NCT02932891An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT05148689A Study Comparing Oxymetazoline 1% Cream to RHOFADE
NCT02343627Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail
NCT01742663A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis
NCT01513863A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
NCT00321087A Study of T2000 in Essential Tremor
NCT02935036Efficacy Study in Patients With Acne Vulgaris.
NCT04883736A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris
NCT02985736Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray
NCT02411942Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris
NCT03645499An Open-Label Study to Assess Safety
NCT01119742Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis
NCT01519752A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis
NCT04358770Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
NCT04321070Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris
NCT01742637Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02618759Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis
NCT03433378To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
NCT03427554To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris
NCT02933528Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS
NCT02932878An Open Label, Safety Study to Assess the Potential for Adrenal Suppression
NCT04797793A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris